Written by: Sandeep Ravindran, Ph.D. | Issue # 44 | 2015
- Allergy to cow’s milk is one of the most common food allergies in young children.
- The probiotic bacteria Lactobacillus rhamnosus GG have been shown to be effective in treating cow’s milk allergy, but how they do so is unclear.
- A new study finds that when infants were given L. rhamnosus GG, those who became tolerant to their allergy had very different gut bacteria than those who remained allergic to cow’s milk.
- In particular, infants who developed tolerance had higher levels of bacteria that produce the fatty acid butyrate, which is known to help maintain a healthy gut.
- Follow-up studies could help identify bacterial strains that serve as more effective treatments against food allergies.
Whether it’s to nuts, cow’s milk, eggs, or some other food, food allergies have become increasingly common in recent decades (1-4). Allergy to cow’s milk is especially common, affecting up to 3% of children worldwide (5). There have been many recent efforts to treat cow’s milk allergy, and probiotics have looked particularly promising. Recent studies have shown that feeding infants formula supplemented with the probiotic Lactobacillus rhamnosus GG (LGG) results in higher rates of tolerance to cow’s milk compared to infants fed unsupplemented formula (6,7).
In a new study, researchers from the University of Naples and the University of Chicago found that infants who developed tolerance to cow’s milk allergy after treatment with LGG-supplemented formula had significantly different gut bacteria from those who remain allergic (8). They compared bacteria in stool samples collected from healthy infants, infants with cow’s milk allergy who had been fed LGG-supplemented formula, and those fed formula without probiotics. “What we were surprised about was that we were able to so specifically see that children treated that didn’t gain tolerance had a very different microbial genetic profile,” says Jack Gilbert, a microbial ecologist at the University of Chicago and Argonne National Laboratory, and one of the co-authors of the study. “So it looks like you have to have the right kinds of bugs already in you, and then if you have them in you then you can benefit from that treatment,” he says.
The children who developed tolerance had higher levels of bacteria that produce the fatty acid butyrate, which is known to be helpful for maintaining a healthy gut (9). “The fact that this probiotic expands the abundance of these butyrate-producing bacteria in the gut of children who have those bacterial organisms already present is brilliant,” says Gilbert. “The key element of this work is that we had no idea why the treatment of patients with that particular probiotic organism had any efficacy at all, because the organism appeared to not remain resident in the gut,” he says. “Yet for some reason treatment with that probiotic had an impact on the induction of tolerance, so that was an enigma,” he says.
The findings could help develop more effective probiotic treatments against cow’s milk allergy, says Gilbert. Similar treatments may eventually help with other allergies as well, although this will require a lot more work, he says. “We believe that having the right kind of bacteria in your body in the right place may be highly effective in treating these conditions,” Gilbert says.
Gilbert and his colleagues are planning to test the influence of different butyrate-producing bacteria on allergic tolerance in mouse models. “We might not even need the treatment with the L. rhamnosus probiotic, we might just be able to give them the bacterial probiotic of the organisms which we think are responsible for inducing tolerance,” Gilbert says. “It’s quite possible that just the addition of that one organism will affect the animal’s or human’s tolerance acquisition,” he says.
The researchers will eventually test the effectiveness of these probiotic treatments in humans. “We should be able to move into clinical trials within one to two years,” Gilbert says. Once researchers identify bacterial species that are particularly effective at treating allergies, they could be added to formula or in a food to be used as therapeutics, he says. “We’re getting close to the point where we think we understand the right kinds of organisms to add,” Gilbert says.
“We already know that the addition of probiotics helps children,” Gilbert says. “We think if we can figure out which probiotics to add to boost their system more effectively, then we’ll have a much more effective treatment,” he says.
1. Prescott SL, Pawankar R, Allen KJ, Campbell DE, Sinn JK, Fiocchi A, et al. A global survey of changing patterns of food allergy burden in children. World Allergy Organ J. BioMed Central Ltd; 2013;6(1):21.
2. Wang J, Sampson HA. Food allergy. J Clin Invest. American Society for Clinical Investigation; 2011 Mar;121(3):827–35.
3. Branum AM, Lukacs SL. Food allergy among children in the United States. Pediatrics. American Academy of Pediatrics; 2009 Dec;124(6):1549–55.
4. Osborne NJ, Koplin JJ, Martin PE, Gurrin LC, Lowe AJ, Matheson MC, et al. Prevalence of challenge-proven IgE-mediated food allergy using population-based sampling and predetermined challenge criteria in infants. J Allergy Clin Immunol. Elsevier; 2011 Mar;127(3):668–76.e1–2.
5. Sicherer SH. Epidemiology of food allergy. J Allergy Clin Immunol. Elsevier; 2011 Mar;127(3):594–602.
6. Berni Canani R, Nocerino R, Terrin G, Coruzzo A, Cosenza L, Leone L, et al. Effect of Lactobacillus GG on tolerance acquisition in infants with cow’s milk allergy: a randomized trial. J Allergy Clin Immunol. Elsevier; 2012 Feb;129(2):580–2–582.e1–5.
7. Berni Canani R, Nocerino R, Terrin G, Frediani T, Lucarelli S, Cosenza L, et al. Formula selection for management of children with cow’s milk allergy influences the rate of acquisition of tolerance: a prospective multicenter study. J Pediatr. Elsevier; 2013 Sep;163(3):771–1.
8. Berni Canani R, Sangwan N, Stefka AT, Nocerino R, Paparo L, Aitoro R, et al. Lactobacillus rhamnosus GG-supplemented formula expands butyrate-producing bacterial strains in food allergic infants. ISME J. Nature Publishing Group; 2015 Sep 22.
9. Canani RB, Costanzo MD, Leone L, Pedata M, Meli R, Calignano A. Potential beneficial effects of butyrate in intestinal and extraintestinal diseases. World J Gastroenterol. 2011 Mar 28;17(12):1519–28.